FIELD OF THE INVENTION
The present invention relates to compounds that act as specific inhibitors of the cysteine protease dipeptidyl peptidase I (DP I). Compounds based on acylated hydroxamates are distinguished by being chemically stable in aqueous solutions, including biological fluids (Bromme
This application is the U.S. National Phase of International Application PCT/CA00/00147, filed Feb. 11, 2000, published in English under PCT Article 21(2), which designated the U.S. PCT/CA00/00147 claims priority to Canadian Patent Application No. 2,260,376, filed Feb. 11, 1999. The entire content